Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $58.93 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $27.38 | 1 | $0 (2024) |
| Abbott Laboratories | $20.23 | 1 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $11.32 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27.38 | 1 | Dendreon Pharmaceuticals LLC ($27.38) |
| 2018 | $11.32 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($11.32) |
| 2017 | $20.23 | 1 | Abbott Laboratories ($20.23) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/27/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/05/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Oncology | ||||||
| 08/01/2017 | Abbott Laboratories | Vysis MultiVysion Probes (Device), Vysis MultiVysion Probes, Vysis MultiVysion Probes | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Molecular Diagnostics | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 7,867 | 19,122 | $10.2M | $2.7M |
| 2022 | 26 | 8,717 | 20,435 | $7.5M | $1.9M |
| 2021 | 25 | 10,858 | 24,761 | $7.1M | $1.6M |
| 2020 | 18 | 6,998 | 21,978 | $6.6M | $1.2M |
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 81162 | Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants | Office | 2023 | 425 | 425 | $2.2M | $756,689 | 35.1% |
| 81455 | Targeted genomic sequence analysis panel of dna or combine dna and rna of 51 or greater genes associated with blood and lymphatic system disorders | Office | 2023 | 112 | 112 | $710,488 | $320,456 | 45.1% |
| 88120 | Cell examination of urine, manual | Office | 2023 | 480 | 584 | $890,402 | $273,675 | 30.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,328 | 5,686 | $2.2M | $264,047 | 12.1% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Office | 2023 | 526 | 1,292 | $568,327 | $172,963 | 30.4% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 514 | 2,056 | $540,039 | $171,857 | 31.8% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 897 | 2,867 | $743,380 | $144,221 | 19.4% |
| 88377 | Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | Office | 2023 | 259 | 477 | $368,260 | $134,851 | 36.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 1,008 | 1,608 | $653,481 | $114,454 | 17.5% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2023 | 539 | 542 | $376,740 | $109,430 | 29.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 456 | 1,318 | $517,281 | $85,209 | 16.5% |
| 88108 | Cell examination of specimen, concentration technique | Office | 2023 | 485 | 539 | $157,840 | $27,027 | 17.1% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Office | 2023 | 53 | 68 | $43,830 | $14,966 | 34.1% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2023 | 384 | 461 | $45,012 | $10,478 | 23.3% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 17 | 451 | $43,386 | $8,974 | 20.7% |
| 88381 | Preparation of specimen, manual | Office | 2023 | 40 | 41 | $16,508 | $6,766 | 41.0% |
| 88360 | Microscopic genetic analysis of tumor, manual | Office | 2023 | 53 | 74 | $23,762 | $6,379 | 26.8% |
| 81479 | Molecular pathology procedure | Office | 2023 | 17 | 17 | $5,066 | $4,665 | 92.1% |
| 81309 | Gene analysis (partner and localizer of brca2) targeted sequence analysis | Office | 2023 | 16 | 16 | $54,720 | $4,309 | 7.9% |
| 88275 | Chromosome analysis for genetic defects, analyze 100-300 cells | Office | 2023 | 15 | 76 | $17,404 | $3,813 | 21.9% |
| 81311 | Gene analysis for cancer (neuroblastoma) | Office | 2023 | 13 | 13 | $9,607 | $3,768 | 39.2% |
| 88271 | Dna testing for genetic defects | Office | 2023 | 15 | 148 | $35,372 | $3,107 | 8.8% |
| 81275 | Gene analysis (v-ki-ras2 kirsten rat sarcoma viral oncogene) variants in codons 12 and 13 | Office | 2023 | 14 | 14 | $6,762 | $2,651 | 39.2% |
| 81210 | Gene analysis (v-raf murine sarcoma viral oncogene homolog b1) | Office | 2023 | 12 | 12 | $5,268 | $2,063 | 39.2% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 36 | 40 | $4,320 | $1,387 | 32.1% |
About Dr. Jim Lu, MD
Dr. Jim Lu, MD is a Anatomic Pathology healthcare provider based in Buffalo Grove, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073590337.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jim Lu, MD has received a total of $58.93 in payments from pharmaceutical and medical device companies, with $27.38 received in 2024. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($58.93).
As a Medicare-enrolled provider, Lu has provided services to 34,440 Medicare beneficiaries, totaling 86,296 services with total Medicare billing of $7.3M. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Other Specialties Anatomic Pathology
- Location Buffalo Grove, IL
- Active Since 12/28/2005
- Last Updated 08/03/2023
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1073590337
Products in Payments
- PROVENGE (Drug) $27.38
- Vysis MultiVysion Probes (Device) $20.23
- Xofigo (Drug) $11.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.